Suppr超能文献

肼屈嗪对高血压大鼠肠系膜血管系统的作用。

Effect of hydralazine on the mesenteric vasculature of hypertensive rats.

作者信息

Smeda J S, Lee R M

机构信息

Department of Anaesthesia, McMaster University, Hamilton, Ontario, Canada.

出版信息

Hypertension. 1991 Apr;17(4):526-33. doi: 10.1161/01.hyp.17.4.526.

Abstract

To test whether structural alterations observed in the mesenteric vasculature of Wistar-Kyoto spontaneously hypertensive rats (SHR) were dependent on the presence of hypertension, male SHR and Wistar-Kyoto normotensive (WKY) rats were treated in utero and postnatally with hydralazine up to 28 weeks of age. Treated SHR, WKY, and untreated WKY rats had comparable blood pressures that were less than those of untreated SHR. Treatment altered the dimensions of the superior mesenteric, intermediate-sized, and small arteries of the mesenteric vasculature. In the case of the superior mesenteric artery and intermediate vessels, hydralazine treatment increased the lumen and medial cross-sectional areas of the arteries in WKY rats and slightly decreased both parameters in SHR. Within the small arteries, treatment significantly increased the lumen size in SHR but not WKY rats and had no significant effect on the media of the vessels. Despite the above alterations, the media-to-lumen cross-sectional area ratios remained significantly elevated in SHR over WKY rats in both the treated and control groups of animals within all classes of arteries. The results indicate that there is an inherent increase in the quantity of media surrounding the arteries of SHR when compared with WKY rats that cannot be abolished by normalizing the blood pressure in utero and postnatally with hydralazine treatment. In SHR, such changes persist not only in arteries that exhibit an increase in the media-to-lumen ratio before hypertension but also in the superior mesenteric artery in which an increase in the ratio occurs after hypertension development.

摘要

为了测试在Wistar-Kyoto自发性高血压大鼠(SHR)肠系膜血管中观察到的结构改变是否依赖于高血压的存在,对雄性SHR和Wistar-Kyoto正常血压(WKY)大鼠在子宫内和出生后用肼屈嗪治疗至28周龄。经治疗的SHR、WKY和未治疗的WKY大鼠具有可比的血压,且低于未治疗的SHR。治疗改变了肠系膜血管的肠系膜上动脉、中等大小动脉和小动脉的尺寸。对于肠系膜上动脉和中等大小血管,肼屈嗪治疗增加了WKY大鼠动脉的管腔和中膜横截面积,而在SHR中这两个参数略有下降。在小动脉中,治疗显著增加了SHR的管腔大小,但对WKY大鼠没有影响,并且对血管中膜没有显著影响。尽管有上述改变,但在所有动脉类别中,治疗组和对照组动物中,SHR的中膜与管腔横截面积之比仍显著高于WKY大鼠。结果表明,与WKY大鼠相比,SHR动脉周围中膜数量存在内在增加,这种增加不能通过子宫内和出生后用肼屈嗪治疗使血压正常化而消除。在SHR中,这种变化不仅存在于高血压前中膜与管腔比增加的动脉中,也存在于高血压发生后该比值增加的肠系膜上动脉中。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验